Islam Hussein is a dedicated virologist with over 18 years of experience in both academia and the pharmaceutical industry. Currently a Principal Scientist at Merck, Islam serves as the Global Clinical Virology Lead for Clesrovimab, supporting global regulatory filings and managing late-stage clinical programs. Previously, Islam held various roles including Senior Scientist at Microbiotix, Inc., and Research Scientist at the Massachusetts Institute of Technology. Islam earned a Ph.D. in Molecular Virology from the University of Cambridge and has contributed to numerous antiviral research initiatives throughout their career.
This person is not in the org chart
This person is not in any teams
This person is not in any offices